Prostatic Adenocarcinoma
Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
5
Immune Histochemical Evaluation of AMACR (P504S) in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia in Small Neddle Biopsy of Sudanese Patients
7
Visualization of early prostatic adenocarcinoma as a stem cell disease
10
A Clinico Pathological Study of Associated Lesions in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma In Surgical Biopsy Specimens
75
Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
6
Original Article Expression of Snail transcription factor in prostatic adenocarcinoma in Egypt: correlation with Maspin protein expression and clinicopathologic variables
9
Role of Immunohistochemical Markers in Differential Diagnosis of Prostatic Adenocarcinoma And Its Mimickers.
113
Effect of gyromagnetic fields on human prostatic adenocarcinoma cells
9
p27kip1 acts as a downstream effector of and is coexpressed with the β1C integrin in prostatic adenocarcinoma
10
Diagnostic utility of p501s (prostein) in comparison to prostate specific antigen (PSA) for the detection of metastatic prostatic adenocarcinoma
7
Immunohistochemical analysis of ezrin-radixin-moesin-binding phosphoprotein 50 in prostatic adenocarcinoma
8
Immune Histochemical Evaluation of Cyclin D1 in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia in Small Neddle Biopsy of Sudanese Patient
7
Case Report Carcinosarcoma of the prostate in a patient with previous prostatic adenocarcinoma, status post brachytherapy
9
Grading of prostatic adenocarcinoma: current state and prognostic implications
8
Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens
5
Evaluation of c-Myc mRNA Expression Level in Benign Prostatic Hyperplasia and Prostatic Adenocarcinoma Tissues and Its Correlation with Clinicopathological Characteristics
10
To determine the effectiveness of immunohistochemistry in differentiating prostatic adenocarcinoma from cancer mimickers
130
Comparison of Matrix Metalloproteinases 2 mRNA Expression in Prostatic Adenocarcinoma and Benign Prostatic Hyperplasia
12
S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors
6
ERG oncoprotein expression in prostatic acinar adenocarcinoma; clinicopathologic significance
5